Log in

NYSE:GEN - Genesis Healthcare Stock Price, Forecast & News

$0.80
-0.04 (-4.61 %)
(As of 03/29/2020 04:00 PM ET)
Today's Range
$0.78
Now: $0.80
$0.84
50-Day Range
$0.79
MA: $1.40
$1.77
52-Week Range
$0.73
Now: $0.80
$1.86
Volume309,929 shs
Average Volume527,057 shs
Market Capitalization$132.06 million
P/E RatioN/A
Dividend YieldN/A
Beta0.97
Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2018, it provided inpatient services through a network of 425 skilled nursing and assisted/senior living facilities, including 399 skilled nursing facilities and 26 stand-alone assisted/senior living facilities across 29 states. Genesis HealthCare, Inc. also supplies rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 46 states and the District of Columbia. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.
Read More
Genesis Healthcare logo

Industry, Sector and Symbol

Industry Skilled nursing care facilities
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone610-444-6350

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.57 billion
Cash Flow$0.80 per share
Book Value($6.57) per share

Profitability

Net Income$14.62 million

Miscellaneous

Employees55,000
Market Cap$132.06 million
Next Earnings Date5/14/2020 (Estimated)
OptionableOptionable

Receive GEN News and Ratings via Email

Sign-up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter.


Genesis Healthcare (NYSE:GEN) Frequently Asked Questions

How has Genesis Healthcare's stock been impacted by COVID-19 (Coronavirus)?

Genesis Healthcare's stock was trading at $1.16 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, GEN shares have decreased by 30.9% and is now trading at $0.8013. View which stocks have been mosted impacted by Coronavirus.

When is Genesis Healthcare's next earnings date?

Genesis Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Genesis Healthcare.

How were Genesis Healthcare's earnings last quarter?

Genesis Healthcare Inc (NYSE:GEN) announced its earnings results on Monday, March, 16th. The company reported ($0.10) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.01. The business had revenue of $1.14 billion for the quarter. Genesis Healthcare had a net margin of 0.32% and a negative return on equity of 1.33%. During the same quarter last year, the firm posted ($0.67) EPS. View Genesis Healthcare's earnings history.

Has Genesis Healthcare been receiving favorable news coverage?

Media headlines about GEN stock have trended somewhat positive on Sunday, InfoTrie Sentiment reports. The research firm identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Genesis Healthcare earned a news sentiment score of 1.9 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutGenesis Healthcare.

Are investors shorting Genesis Healthcare?

Genesis Healthcare saw a drop in short interest during the month of February. As of February 28th, there was short interest totaling 2,280,000 shares, a drop of 30.7% from the February 13th total of 3,290,000 shares. Based on an average daily trading volume, of 208,900 shares, the short-interest ratio is presently 10.9 days. Approximately 4.2% of the shares of the company are sold short. View Genesis Healthcare's Current Options Chain.

Who are some of Genesis Healthcare's key competitors?

What other stocks do shareholders of Genesis Healthcare own?

Who are Genesis Healthcare's key executives?

Genesis Healthcare's management team includes the following people:
  • Mr. George V. Hager Jr., CEO & Director (Age 63)
  • Mr. Thomas DiVittorio, CFO, Exec. VP, Treasurer & Assistant Sec. (Age 51)
  • Mr. Paul David Bach, COO & Exec. VP (Age 60)
  • Dr. JoAnne Susan Reifsnyder Ph.D., MSN, MBA, FAAN, Exec. VP of Clinical Operations & Chief Nursing Officer (Age 60)
  • Mr. Richard L. Castor, Chief Information Officer & Sr. VP (Age 64)

What is Genesis Healthcare's stock symbol?

Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."

Who are Genesis Healthcare's major shareholders?

Genesis Healthcare's stock is owned by a number of retail and institutional investors. Top institutional shareholders include First Washington CORP (2.54%), Renaissance Technologies LLC (2.53%), Chevy Chase Trust Holdings Inc. (1.59%), Acadian Asset Management LLC (0.98%), State Street Corp (0.73%) and Panagora Asset Management Inc. (0.59%). Company insiders that own Genesis Healthcare stock include David A Reis, Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, Stephen Scott Young and Thomas Divittorio. View institutional ownership trends for Genesis Healthcare.

Which major investors are selling Genesis Healthcare stock?

GEN stock was sold by a variety of institutional investors in the last quarter, including BSW Wealth Partners, Goldman Sachs Group Inc., Virtu Financial LLC, California Public Employees Retirement System, Nuveen Asset Management LLC, and Principal Financial Group Inc.. Company insiders that have sold Genesis Healthcare company stock in the last year include Joanne Susan Reifsnyder, Michael Scott Sherman, Paul David Bach, and Thomas Divittorio. View insider buying and selling activity for Genesis Healthcare.

Which major investors are buying Genesis Healthcare stock?

GEN stock was acquired by a variety of institutional investors in the last quarter, including First Washington CORP, Renaissance Technologies LLC, Chevy Chase Trust Holdings Inc., Panagora Asset Management Inc., State Street Corp, Acadian Asset Management LLC, Barclays PLC, and UBS Group AG. View insider buying and selling activity for Genesis Healthcare.

How do I buy shares of Genesis Healthcare?

Shares of GEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Genesis Healthcare's stock price today?

One share of GEN stock can currently be purchased for approximately $0.80.

How big of a company is Genesis Healthcare?

Genesis Healthcare has a market capitalization of $132.06 million and generates $4.57 billion in revenue each year. The company earns $14.62 million in net income (profit) each year or $0.10 on an earnings per share basis. Genesis Healthcare employs 55,000 workers across the globe. View additional information about Genesis Healthcare.

What is Genesis Healthcare's official website?

The official website for Genesis Healthcare is http://www.genesishcc.com/.

How can I contact Genesis Healthcare?

Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected]


MarketBeat Community Rating for Genesis Healthcare (NYSE GEN)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  451 (Thanks for Voting!)
Underperform Votes:  388 (Thanks for Voting!)
Total Votes:  839
MarketBeat's community ratings are surveys of what our community members think about Genesis Healthcare and other stocks. Vote "Outperform" if you believe GEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Featured Article: What is Liquidity?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel